# David L. Porter

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/david-l-porter/

## Facts

| Field | Value |
| --- | --- |
| Citations | 866 |
| Field | CAR-T cell therapy research |
| h-index | 11 |
| i10-index | 11 |
| Last Known Institution | Hospital of the University of Pennsylvania |
| OpenAlex ID | https://openalex.org/A5103007968 |
| ORCID iD | 0000-0002-0748-8374 |
| Works | 44 |

## Researcher papers

- [Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation](https://scholariq.org/papers/adoptive-transfer-of-costimulated-t-cells-induces-lymphocytosis-in-patients-with/)
- [CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration](https://scholariq.org/papers/cd19-targeting-car-t-cell-immunotherapy-outcomes-correlate-with-genomic/)
- [The Graft-Versus-Leukemia Effects of Allogeneic Cell Therapy](https://scholariq.org/papers/the-graft-versus-leukemia-effects-of-allogeneic-cell-therapy/)
- [CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication](https://scholariq.org/papers/ccr5-edited-cd4-t-cells-augment-hiv-specific-immunity-to-enable-post-rebound/)
- [BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia](https://scholariq.org/papers/bet-bromodomain-protein-inhibition-reverses-chimeric-antigen-receptor-extinction/)
- [Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies](https://scholariq.org/papers/long-term-safety-of-lentiviral-or-gammaretroviral-gene-modified-t-cell-therapies/)
- [Regulation of erythropoietin production.](https://scholariq.org/papers/regulation-of-erythropoietin-production/)
- [TET2 regulates early and late transitions in exhausted CD8 <sup>+</sup> T cell differentiation and limits CAR T cell function](https://scholariq.org/papers/tet2-regulates-early-and-late-transitions-in-exhausted-cd8-sup-sup-t-cell/)
- [Umbilical Cord Blood Xenografts in Immunodeficient Mice Reveal That T Cells Enhance Hematopoietic Engraftment Beyond Overcoming Immune Barriers by Stimulating Stem Cell Differentiation](https://scholariq.org/papers/umbilical-cord-blood-xenografts-in-immunodeficient-mice-reveal-that-t-cells/)
- [An improved in situ hybridization method](https://scholariq.org/papers/an-improved-in-situ-hybridization-method/)
- [Factors Related to Long-Term Caregiving Burden Among Chimeric Antigen Receptor (CAR) T-Cell Recipients and Their Informal Caregivers](https://scholariq.org/papers/factors-related-to-long-term-caregiving-burden-among-chimeric-antigen-receptor/)

## Researcher topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Biomedical Ethics and Regulation](https://scholariq.org/topics/biomedical-ethics-and-regulation/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)

## Researcher university

- [Hospital of the University of Pennsylvania](https://scholariq.org/institutions/hospital-of-the-university-of-pennsylvania/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.